268 related articles for article (PubMed ID: 33006813)
1. The immunomodulatory effects of mesenchymal stromal cell-based therapy in human and animal models of systemic lupus erythematosus.
Radmanesh F; Mahmoudi M; Yazdanpanah E; Keyvani V; Kia N; Nikpoor AR; Zafari P; Esmaeili SA
IUBMB Life; 2020 Nov; 72(11):2366-2381. PubMed ID: 33006813
[TBL] [Abstract][Full Text] [Related]
2. Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors?
El-Jawhari JJ; El-Sherbiny Y; McGonagle D; Jones E
Front Immunol; 2021; 12():643170. PubMed ID: 33732263
[TBL] [Abstract][Full Text] [Related]
3. Lupus mice derived mesenchymal stromal cells: Beneficial or detrimental on SLE disease outcome.
Hosseini S; Mahmoudi M; Rezaieyazdi Z; Shapouri-Moghaddam A; Hosseinzadeh A; Arab FL; Tabasi NS; Esmaeili SA
Int Immunopharmacol; 2024 Jan; 126():111306. PubMed ID: 38039717
[TBL] [Abstract][Full Text] [Related]
4. Dysregulated balance in Th17/Treg axis of Pristane-induced lupus mouse model, are mesenchymal stem cells therapeutic?
Hoseinzadeh A; Rezaieyazdi Z; Mahmoudi M; Tavakol Afshari J; Lavi Arab F; Esmaeili SA; Faridzadeh A; Rezaeian A; Hoseini S; Barati M; Mahmoudi A; Sadat Tabasi N
Int Immunopharmacol; 2023 Apr; 117():109699. PubMed ID: 36867923
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal Stem Cell Therapy: Hope for Patients With Systemic Lupus Erythematosus.
Li A; Guo F; Pan Q; Chen S; Chen J; Liu HF; Pan Q
Front Immunol; 2021; 12():728190. PubMed ID: 34659214
[TBL] [Abstract][Full Text] [Related]
6. Serum IFN-γ Predicts the Therapeutic Effect of Mesenchymal Stem Cells Transplantation in Systemic Lupus Erythematosus Patients.
Wang D; Wang S; Huang S; Zhang Z; Yuan X; Feng X; Lu L; Sun L
Stem Cells Transl Med; 2017 Sep; 6(9):1777-1785. PubMed ID: 28755405
[TBL] [Abstract][Full Text] [Related]
7. Functional Characteristics and Application of Mesenchymal Stem Cells in Systemic Lupus Erythematosus.
Tang WY; Liu JH; Peng CJ; Liao Y; Luo JS; Sun X; Tang YL; Luo XQ
Arch Immunol Ther Exp (Warsz); 2021 Mar; 69(1):7. PubMed ID: 33713197
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor signalling associated with immunomodulation of umbilical cord-derived mesenchymal stem cells in mice with systemic lupus erythematosus.
Wu KH; Cheng CC; Li JP; Weng TF; Yang SF; Pan HH; Chao YH
Lupus; 2020 Feb; 29(2):165-175. PubMed ID: 31964222
[TBL] [Abstract][Full Text] [Related]
9. Modulation of Mesenchymal Stem Cells-Mediated Adaptive Immune Effectors' Repertoire in the Recovery of Systemic Lupus Erythematosus.
Hoseinzadeh A; Rezaieyazdi Z; Afshari JT; Mahmoudi A; Heydari S; Moradi R; Esmaeili SA; Mahmoudi M
Stem Cell Rev Rep; 2023 Feb; 19(2):322-344. PubMed ID: 36272020
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cell transplantation in systemic lupus erythematous, a mesenchymal stem cell disorder.
Fathollahi A; Gabalou NB; Aslani S
Lupus; 2018 Jun; 27(7):1053-1064. PubMed ID: 29631514
[TBL] [Abstract][Full Text] [Related]
11. Combined transplantation of autologous hematopoietic stem cells and allogenic mesenchymal stem cells increases T regulatory cells in systemic lupus erythematosus with refractory lupus nephritis and leukopenia.
Wang Q; Qian S; Li J; Che N; Gu L; Wang Q; Liu Y; Mei H
Lupus; 2015 Oct; 24(11):1221-6. PubMed ID: 25914407
[TBL] [Abstract][Full Text] [Related]
12. Metformin enhances the immunomodulatory potential of adipose-derived mesenchymal stem cells through STAT1 in an animal model of lupus.
Jang SG; Lee J; Hong SM; Kwok SK; Cho ML; Park SH
Rheumatology (Oxford); 2020 Jun; 59(6):1426-1438. PubMed ID: 31904843
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone-Integrated Mesenchymal Stem Cells for Systemic Lupus Erythematosus Treatment
Ma W; Che J; Chen W; Wang D; Zhang H; Zhao Y
ACS Nano; 2024 May; 18(20):13249-13265. PubMed ID: 38720584
[TBL] [Abstract][Full Text] [Related]
14. Allogenic Umbilical Cord-Derived Mesenchymal Stromal Cells Sustain Long-Term Therapeutic Efficacy Compared With Low-Dose Interleukin-2 in Systemic Lupus Erythematosus.
Cao Z; Wang D; Jing L; Wen X; Xia N; Ma W; Zhang X; Jin Z; Shen W; Yao G; Chen W; Tang X; Geng L; Li H; Li X; Ding S; Liang J; Feng X; Zhang H; Liu S; Li W; Sun L
Stem Cells Transl Med; 2023 Jul; 12(7):431-443. PubMed ID: 37279956
[TBL] [Abstract][Full Text] [Related]
15. Transplantation of mesenchymal stem cells ameliorates systemic lupus erythematosus and upregulates B10 cells through TGF-β1.
Chun W; Tian J; Zhang Y
Stem Cell Res Ther; 2021 Sep; 12(1):512. PubMed ID: 34563233
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Applications of Mesenchymal Stem Cells for Systemic Lupus Erythematosus.
Xu J
Adv Exp Med Biol; 2018; 1089():73-85. PubMed ID: 29767288
[TBL] [Abstract][Full Text] [Related]
17. Genetic contribution to mesenchymal stem cell dysfunction in systemic lupus erythematosus.
Zhu Y; Feng X
Stem Cell Res Ther; 2018 May; 9(1):149. PubMed ID: 29793537
[TBL] [Abstract][Full Text] [Related]
18. Prospects for the Application of Transplantation With Human Amniotic Membrane Epithelial Stem Cells in Systemic Lupus Erythematosus.
Xu L; Dai Q; Zhang Y; Lin N; Ji L; Song X
Cell Transplant; 2024; 33():9636897241236586. PubMed ID: 38469823
[TBL] [Abstract][Full Text] [Related]
19. Additive Therapeutic Effects of Mesenchymal Stem Cells and IL-37 for Systemic Lupus Erythematosus.
Xu J; Chen J; Li W; Lian W; Huang J; Lai B; Li L; Huang Z
J Am Soc Nephrol; 2020 Jan; 31(1):54-65. PubMed ID: 31604808
[TBL] [Abstract][Full Text] [Related]
20. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus.
Schena F; Gambini C; Gregorio A; Mosconi M; Reverberi D; Gattorno M; Casazza S; Uccelli A; Moretta L; Martini A; Traggiai E
Arthritis Rheum; 2010 Sep; 62(9):2776-86. PubMed ID: 20496367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
